2-piperidone has been researched along with Arterial Occlusive Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukai, M; Igarashi, R; Kobayashi, N; Ogura, M; Shibasaki, S; Todo, S; Tsunetoshi, Y; Umezawa, K; Yamashita, K; Yoshida, T; Zaitsu, M | 1 |
1 other study(ies) available for 2-piperidone and Arterial Occlusive Diseases
Article | Year |
---|---|
3-[(dodecylthiocarbonyl)methyl]-glutarimide attenuates graft arterial disease by suppressing alloimmune responses and vascular smooth muscle cell proliferation.
Topics: Animals; Arterial Occlusive Diseases; Cells, Cultured; Heart Transplantation; Histocompatibility Testing; Interferon-gamma; Isoantibodies; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Piperidones; Transplantation, Homologous | 2015 |